CSIMarket
 



X4 Pharmaceuticals Inc  (XFOR)
Other Ticker:  
 



X4 Pharmaceuticals Inc's Debt Coverage ratios

XFOR's Debt and Ebitda growth


XFOR Debt Coverage (Mar 31 2024)
I. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
III. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Total Debt Change - - -91.12 % -83.78 % 65.41 %
Y / Y Ebitda Change - - - - -
Debt Coverage (TTM) - - - - -
Total Ranking # # # # #
Seq. Total Debt Change - - 37.91 % -57.87 % -91.01 %
Seq. Ebitda Change - - - - -





Debt Coverage Ratio first quarter of 2024 Comment
Company recorded operating loss in the Q1 2024.

Within Healthcare sector X4 Pharmaceuticals Inc achieved highest debt coverage ratio in the first quarter of 2024. While debt coverage ratio ranking remained unchanged in the Q1 2024 compared to the third quarter 2023 at no. .
Debt Coverage Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #


Debt Coverage Ratio Statistics
High Average Low
0 0 0
 



Financial Statements
X4 Pharmaceuticals Inc's Total Debt $ 0 Millions Visit XFOR's Balance sheet
X4 Pharmaceuticals Inc's Ebitda $ -50 Millions Visit XFOR's Income Statement
Where are XFOR's Sales coming from? Visit XFOR's Sales by Geography




Companies with similar Debt Coverage Mar 31 2024, within Healthcare Sector Debt Coverage
Date modified: 2024-05-08T15:34:55+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright Š 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com